The purpose of neurometabolic screening is the earliest possible detection of treatable disorders. The disorders currently offered to general population screening are phenylketonuria, congenital hypothyroidism, galactosemia, congenital adrenal hyperplasia, cystic fibrosis, biotinidase deficiency, maple syrup urine disease, sickle cell disease, homocystinuria. The methods used for these evaluations are mass spectroscopy and genetic testing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[updating neonatal
4
neonatal neurometabolic
4
neurometabolic screening]
4
screening] purpose
4
purpose neurometabolic
4
neurometabolic screening
4
screening earliest
4
earliest detection
4
detection treatable
4
treatable disorders
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!